Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication

被引:20
|
作者
Taskin, Orhun Cig [1 ]
Clarke, Callisia N. [2 ]
Erkan, Mert [3 ,4 ]
Tsai, Susan [2 ]
Evans, Douglas B. [2 ]
Adsay, Volkan [1 ]
机构
[1] Koc Univ Hosp, Dept Pathol, Davutpasa Caddesi 4, TR-34010 Istanbul, Turkey
[2] Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA
[3] Koc Univ Hosp, Dept Surg, Istanbul, Turkey
[4] Koc Univ, Res Ctr Translat Med, Istanbul, Turkey
关键词
Pancreas; neuroendocrine neoplasm; tumor; carcinoma; pathology; terminology; classification; prognosis; WHO; 2019; KI67 PROLIFERATIVE INDEX; CLINICOPATHOLOGICAL ANALYSIS; ENDOCRINE NEOPLASMS; HIGH-GRADE; GASTROENTEROPANCREATIC SYSTEM; CONSENSUS GUIDELINES; LABELING INDEX; CELL-CARCINOMA; TUMORS; EXPRESSION;
D O I
10.21037/jgo.2020.03.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Significant improvements have taken place in our understanding of classification neuroendocrine neoplasms of the pancreas in the past decade. "These are now regarded in three entirely separate categories: (I) neuroendocrine tumors (PanNETs) are by definition well differentiated, the pancreatic counterpart of carcinoids; (II) neuroendocrine carcinomas, which are poorly differentiated (PDNEC), the pancreatic examples of small cell carcinomas or large cell neuroendocrine carcinomas; (III) other neoplasms that have neuroendocrine differentiation or a distinct neuroendocrine component. PanNETs are by far the most common. They are now regarded as malignancies (albeit often curable when low grade and low stage) with the exception of minute incidental proliferations (tumorlets, or dysplastic-like changes) seen in the setting of some syndromes like MEN. PanNETs are staged based on their size, and for small T1 tumors, watchful waiting is now being considered, although these tumors are also known to show about 10% metastatic rate and/or progression, creating concerns about this approach. PanNETs are graded into 3, based on the proliferative activity, mostly based on the Ki-67 index, and also partly mitotic activity, although the latter seldom if ever is the determinant of the final grade. Neuroendocrine neoplasms with well differentiated morphology but Ki-67 >20% are now regarded as Pa.nNFT Grade 3 (G3); they have been shown to have a prognosis significantly worse than lesser grade PanNETs but still incomparably better than frank PDNECs, the latter typically has Ki-67 >50% (often much higher) and require platinum-based chemotherapy. There are also cases that are ambiguous between PanNET-G3 and PDNEC, and very rarely transformation of the former to the latter appears to occur. For low grade (G 1/G2) PanNETs, more refined criteria to further prognosticate this group are needed. Morphologic variants being recognized may bring new perspectives to this group.
引用
收藏
页码:548 / 558
页数:11
相关论文
共 50 条
  • [21] Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies
    Lee, Lingaku
    Ito, Tetsuhide
    Jensen, Robert T.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (09) : 837 - 860
  • [22] Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms
    Crippa, S.
    Partelli, S.
    Boninsegna, L.
    Falconi, M.
    ANNALS OF ONCOLOGY, 2012, 23 (07) : 1928 - 1928
  • [23] Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification
    Khanna, Lokesh
    Prasad, Srinivasa R.
    Sunnapwar, Abhijit
    Kondapaneni, Sainath
    Dasyam, Anil
    Tammisetti, Varaha S.
    Salman, Umber
    Nazarullah, Alia
    Katabathina, Venkata S.
    RADIOGRAPHICS, 2020, 40 (05) : 1240 - 1262
  • [24] Pancreatic neuroendocrine neoplasms: The latest surgical and medical treatment strategies based on the current World Health Organization classification
    Ishida, Hirotaka
    Lam, Alfred King-Yin
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 145
  • [25] Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria
    Sandvik, O. M.
    Soreide, K.
    Gudlaugsson, E.
    Kvaloy, J. T.
    Soreide, J. A.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (03) : 226 - 232
  • [26] Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies
    Fong, Zhi Ven
    Ferrone, Cristina R.
    Lillemoe, Keith D.
    Fernandez-del Castillo, Carlos
    ANNALS OF SURGERY, 2016, 263 (05) : 908 - 917
  • [27] Controversy: asymptomatic small pancreatic neuroendocrine neoplasms Current standards in diagnostics and treatment
    Wiese, D.
    Bartsch, D. K.
    CHIRURGIE, 2022, 93 (08): : 739 - 744
  • [28] Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future
    Ohmoto, Akihiro
    Rokutan, Hirofumi
    Yachida, Shinichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (01):
  • [29] Surgical treatment of non-functioning pancreatic neuroendocrine tumors: current controversies and challenges
    Memeh Kelvin O.
    Vaghaiwalla Tanaz
    Keutgen Xavier M.
    Section of Endocrine Surgery
    胰腺病学杂志(英文), 2020, 03 (02) : 51 - 58
  • [30] Review of the Literature and Current State of Knowledge on the Management of Lung Neuroendocrine Neoplasms
    Jurkiewicz, Krzysztof
    Miciak, Michal
    Kaliszewski, Krzysztof
    CLINICAL CANCER INVESTIGATION JOURNAL, 2023, 12 (06): : 1 - 5